PBT up 77.1% but ROE eased to 9.3% as equity outpaced earnings

NPAT grew 68.4% to NZ$2.3m, lagging PBT because the effective tax rate moved from 29.0% to 32.5%. Despite stronger earnings, return on equity slipped from 9.9% to 9.3% because equity expanded 79.2% to NZ$24.3m — faster than profits. Total assets rose 32.2% to NZ$136.1m and total liabilities (largely term deposits) rose 25.1%. Operating activities consumed NZ$3.4m of cash, consistent with growth in finance receivables. Cash and cash equivalents declined 15.5% to NZ$14.1m as deployment outran funding inflows. No dividend was declared.

PBT growth of 77.1% is genuine, but ROE eased to 9.3% from 9.9% because equity grew 79.2% while NPAT grew 68.4%. This matters because the strategic question for a deposit-taking lender is whether each additional dollar of capital earns the same risk-adjusted return; this period it earned slightly less even on a much larger lending base.

The tax line opened an 8.7pp gap between PBT and NPAT growth. The effective tax rate rose to 32.5% from 29.0%, which means PBT is the cleaner operating read this period. Whether 32.5% becomes the steady-state rate materially affects forward NPAT translation.

Funding mix shifted toward both deposits and equity. Total assets grew NZ$33.2m, funded by NZ$22.5m of additional liabilities (predominantly term deposits) and NZ$10.7m of additional equity. Cash fell NZ$2.6m as the loan book deployment ran ahead of these funding inflows. This is the standard small-deposit-taker scale-up playbook, but it leaves limited cushion if credit losses, deposit outflows, or further growth require fresh equity.

HY23 revenue of NZ$3.5m represented 25.2% of FY23 revenue, while HY23 NPAT of NZ$1.0m represented 46.0% of FY23 NPAT. The implication is that the second half scaled revenue much faster than profit — implied 2H revenue was NZ$10.3m against implied 2H NPAT of NZ$1.2m. The key forward question this release does not answer is whether that 2H revenue run rate is sustainable into FY24, and whether further balance-sheet growth can be funded without additional equity issuance.

PBT growth of 77.1% reflects spread income from a larger book rather than one-offs, and no non-recurring items are flagged. The important nuance is that equity expanded faster than profits, so the capital deployed has not yet translated into a stronger per-dollar return — the ROE decline from 9.9% to 9.3% is the cleanest summary of that.

The NZ$3.4m operating cash outflow is not a conversion problem in the operating-company sense. For a deposit-taking finance business, growth in finance receivables sits inside operating cash flow, so a scaling loan book produces operating outflows by design. The relevant quality question is therefore about credit, not cash conversion: whether the loans written in FY23 are of equivalent credit standing to the prior book. The release references General Finance's BB- credit rating with Stable Outlook from Equifax but does not disclose in-period arrears, impairment movements, or origination-vintage performance — so the durability of this result depends on credit data the release does not provide.

This briefing cannot assess the credit quality of the expanded loan book, the cost dynamics behind the Research and Advisory swing to loss, or the company's forward funding plans, because the release does not include in-period credit metrics, segment commentary, or guidance.